These Δp35 knock in mice express a mutant Cdk5r1 gene product that results in a calpain cleavage-resistant p35 protein. They are suitable for use in applications related to the study of cyclin-dependent kinase 5 activity and neurodegenerative diseases such as Alzheimer's Disease.
Li-Huei Tsai, Massachusetts Institue of Technology
The Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35) gene encodes the p35 protein, which when cleaved by calpain results in a truncated p25 protein. The p25 protein is an activator of cyclin-dependent kinase 5, and as a complex with CDK5 causes hyperphosphorylation of tau and neurofilament proteins, as well as neuronal cell death.
These Δp35 KI mice express a mutant calpain cleavage-resistant p35 protein in which six amino acid residues adjacent to the calpain-cleavage site (Δ93 -98) were deleted with a leucine replacing the alanine. In mice homozygous for the mutation, expression levels for the mutant protein are similar to wildtype levels. Calpain cleavage of p35 and formation of the p25 truncated protein is abolished in homozygotes while other native CDK5R1 protein activity is unaltered. Homozygotes are viable and fertile, and exhibit impaired memory extinction.
While hippocampal long-term potentiation (LTP) is the same as wildtype controls, hippocampal N-methyl-D-aspartate receptor (NMDAR)-dependent long-term depression (LTD) is compromised.
When crossed with the 5XFAD mouse model of Alzheimer's Disease, Β-amyloid accumulation, synaptic dysfunction and memory impairment is improved in the compound mutant mice when compared with the 5XFAD mice.
The Δp35-3xHA knock-in cassette, encoding for deletion of six amino acid residues adjacent to the calpain-cleavage site (Δ93-98) and leucine replacement of the alanine residue in the cleavage site, was generated via two sequential recombination reactions.
The targeting vector contained this Δp35-3xHA knock-in cassette and a loxP site-flanked NEO cassette. The construct was electroporated into unspecified 129-derived embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts. Heterozygous males were crossed to Meox2-Cre females (on the B6.129S4 background) to remove the floxed NEO cassette. The donating investigator reported that the mice that no longer carried the floxed NEO cassette were then backcrossed to C57BL/6 for at least 8 generations (see SNP note).
Upon arrival at The Jackson Laboratory, the mice were crossed to C57BL/6J (Stock No. 000664) at least once to establish the colony.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. Two of the 27 markers throughout the genome were segregating, suggesting an incomplete backcross. Also, 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
|Allele Name||targeted mutation 2.1, Li-Huei Tsai|
|Allele Synonym(s)||delta p35-3xHA; deltap35KI|
|Gene Symbol and Name||Cdk5r1, cyclin-dependent kinase 5, regulatory subunit 1 (p35)|
|Strain of Origin||129|
|Molecular Note||The deltap35-3xHA knock-in cassette encodes for deletion of the six amino acid residues adjacent to the calpain-cleavage site (delta93-98) and replaces the alanine residue in the cleavage site for leucine., The cassette was generated via two sequential recombination reactions.The final targeting vector contains this deltap35-3xHA knock-in cassette and a loxP site-flanked NEO cassette. Mutant mice were bred with Meox2-cre mice to remove the neo selection cassette.|
When maintaining a live colony, these mice can be bred as homozygotes.
When using the Δp35KI mouse strain in a publication, please cite the originating article(s) and include JAX stock #022401 in your Materials and Methods section.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.